MedPath

PIERIS AUSTRALIA PTY LTD

๐Ÿ‡ฆ๐Ÿ‡บAustralia
Ownership
-
Employees
-
Market Cap
-
Website

Study of Single and Multiple Doses of PRS-220 Administered by Oral Inhalation in Healthy Subjects

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Placebo
First Posted Date
2022-07-26
Last Posted Date
2023-10-23
Lead Sponsor
Pieris Australia Pty Ltd
Target Recruit Count
64
Registration Number
NCT05473533
Locations
๐Ÿ‡ฆ๐Ÿ‡บ

Nucleus Network Pty Ltd., Melbourne, Victoria, Australia

Study of Multiple Doses of PRS-060 Administered by Oral Inhalation in Subjects With Mild Asthma

Phase 1
Completed
Conditions
Asthma
Interventions
Drug: Placebo
First Posted Date
2018-07-02
Last Posted Date
2020-12-24
Lead Sponsor
Pieris Australia Pty Ltd
Target Recruit Count
76
Registration Number
NCT03574805
Locations
๐Ÿ‡ฆ๐Ÿ‡บ

Linear, Nedlands, West Australia, Australia

๐Ÿ‡ฆ๐Ÿ‡บ

CMAX, Adelaide, South Australia, Australia

๐Ÿ‡ฆ๐Ÿ‡บ

Q-Pharm, Herston, Queensland, Australia

and more 1 locations

Study of a Single Dose of PRS-060 Administered by Oral Inhalation or IV Infusion in Healthy Subjects

Phase 1
Completed
Conditions
Healthy Subjects
Interventions
Drug: Placebo
First Posted Date
2017-12-27
Last Posted Date
2020-11-16
Lead Sponsor
Pieris Australia Pty Ltd
Target Recruit Count
72
Registration Number
NCT03384290
Locations
๐Ÿ‡ฆ๐Ÿ‡บ

Nucleus Network Limited, Melbourne, Victoria, Australia

ยฉ Copyright 2025. All Rights Reserved by MedPath